PACS Group (PACS) return on equity (ROE)

Return on equity · fiscal 2025
20.2%

PACS Group (PACS) earned a return on equity of 20.2% in fiscal 2025 (the year ended December 31, 2025). That is 12.4 percentage points higher than the 7.9% of fiscal 2024. Figures as of 17 Nov 2026, 21:22 UTC, from Yahoo Finance.

Key facts

Return on equity, fiscal 2025
20.2%
Change on fiscal 2024
+12.4 pts
Highest on record
236.5%fiscal 2022
Lowest on record
7.9%fiscal 2024
Fiscal years on record
42022–2025

Figures as of . Statements from Yahoo Finance. Figures, not advice.

PACS Group return on equity (ROE), in more detail

Across the 4 fiscal years on record (2022–2025), the highest was 236.5% in fiscal 2022 and the lowest 7.9% in fiscal 2024. The fiscal 2025 figure is higher than in 33% of the 3 earlier fiscal years on record, whose median is 117.4%.

History · 4 fiscal years

Return on equity by fiscal year

PACS Group return on equity (ROE), year by year

PACS Group (PACS) return on equity (ROE) by fiscal year
Fiscal yearReturn on equityChangeYear ended
202520.2% 12.4 pts up
20247.9% 109.6 pts down
2023117.4% 119.0 pts down
2022236.5%—

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

How to read it

It is the profit earned on the owners' capital — above about 15% is strong, though heavy debt or large buybacks can inflate it.

Return on equity at health care companies of similar size

Return on equity of PACS Group and comparable companies
CompanyReturn on equityFiscal year
Alkermes ALKS13.3%2025
PACS Group PACS20.2%2025
Kiniksa Pharmaceuticals International KNSA10.4%2025
ImmunityBio IBRX-130.7%2019
Cytokinetics CYTK-88.3%2021
ABIVAX ABVX-73.8%2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on PACS

PACS Group, figure by figure

PACS Group (PACS) overview: price, valuation and scorecardAll health care companies by market value

PACS Group return on equity (ROE): questions and answers

What is PACS Group's return on equity?

PACS Group (PACS) earned a return on equity of 20.2% in fiscal 2025 (the year ended December 31, 2025). That is 12.4 percentage points higher than the 7.9% of fiscal 2024.

Is PACS Group's return on equity high or low compared with its own history?

The fiscal 2025 figure is higher than in 33% of the 3 earlier fiscal years on record, whose median is 117.4%.

What are the highest and lowest return on equity figures on record for PACS Group?

Across the 4 fiscal years on record (2022–2025), the highest was 236.5% in fiscal 2022 and the lowest 7.9% in fiscal 2024.

How is PACS Group's return on equity calculated?

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “PACS Group (PACS) return on equity (ROE)”, data as of 17 November 2026. https://funkfolio.com/stock/PACS/roe

Underlying data: Yahoo Finance.